The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials
- Citation:
- Cancer Med vol 8 (1) 165-73
- Year:
- 2018
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Meta-Analysis
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 8
- Parents:
- 2572
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U10CA180791, U10CA180833, U10CA180850, U10CA180854, U10CA180866
- Corr. Author:
- Authors:
- Frederick Lansigan Ian Barak Brandelyn Pitcher Sin‐Ho Jung Bruce D. Cheson Myron Czuczman Peter Martin Eric Hsi Heiko Schöder Scott Smith Nancy L. Bartlett John P. Leonard Kristie A. Blum
- Networks:
- CAPITAL, IL017, LAPS-MN026, LAPS-MO011, LAPS-NH012, LAPS-NY016, LAPS-NY158, LAPS-OH007, NY018
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-50402, CALGB-50701, CALGB-50803
- Phases:
- 2
- Keywords: